Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Hits 52-Week High; Stratagene Leads Index

Shares in Bio-Rad Laboratories hit a 52-week high this week, closing Monday at $80.42, up 2.4 percent for the trading period ended Monday — a day earlier than normal due to the Thanksgiving holiday in the US this week. Stratagene led all gainers in the BCW Index with a 7.5 percent jump for the week. Qiagen led decliners for the week with a drop of 4.9 percent.
 
Overall, the Index gained 0.7 percent for the week, lagging the Nasdaq Biotech Index, which gained 1.5 percent; the broader Nasdaq market, which rose 0.9 percent; and the Dow Jones Industrial Average, which climbed 0.8 percent.
 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(November 20, 2006)
Last
Price
(November 14, 2006)
% change
Agilent A
33.74
33.00
2.2
Applied Biosystems ABI
36.81
37.57
-2.0
Beckman BEC
59.92
59.75
0.3
Bio-Rad BIO
80.42
78.52
2.4
Bruker BRKR
7.91
8.00
-1.1
GE GE
35.98
35.59
1.1
Invitrogen IVGN
57.24
57.09
0.3
Millipore MIL
68.64
66.41
3.4
Molecular Devices MDCC
21.39
20.73
3.2
PerkinElmer PKI
21.51
21.64
-0.6
Qiagen QGEN
14.83
15.60
-4.9
Sigma SIAL
76.97
77.42
-0.6
Stratagene STGN
7.21
6.71
7.5
Thermo TMO
43.84
43.71
0.3
Waters WAT
50.74
51.04
-0.6
BCW Index Average  
41.14
40.85
0.7

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.